MIRA Pharmaceuticals, Inc. Earnings Per Share (Basic)
MIRA Pharmaceuticals, Inc. (MIRA) reported Earnings Per Share (Basic) of -$0.03 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-12
- MIRA Pharmaceuticals, Inc. earnings per share, basic for the quarter ending 2026-06-30 was -$0.03.
- MIRA Pharmaceuticals, Inc. earnings per share, basic for the quarter ending 2026-03-31 was -$0.03.
- MIRA Pharmaceuticals, Inc. earnings per share, basic for the quarter ending 2025-12-31 was -$0.15.
- MIRA Pharmaceuticals, Inc. earnings per share, basic for the quarter ending 2025-09-30 was -$1.18.
- MIRA Pharmaceuticals, Inc. earnings per share, basic for fiscal 2025 was -$1.35.
- MIRA Pharmaceuticals, Inc. earnings per share, basic for fiscal 2024 was -$0.51.
- MIRA Pharmaceuticals, Inc. earnings per share, basic for fiscal 2023 was -$0.85.
- MIRA Pharmaceuticals, Inc. earnings per share, basic for fiscal 2022 was -$0.40.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | -$0.03 10-Q · filed 2026-08-12 | -$0.06 10-Q · filed 2026-08-12 | ||||
| 2026-03-31 | -$0.03 10-Q · filed 2026-05-14 | |||||
| 2025-12-31 | -$0.15 derived: net income ÷ weighted average shares · filed 2026-03-31 | -$0.95 derived: net income ÷ weighted average shares · filed 2026-03-31 | -$1.35 10-K · filed 2026-03-31 | |||
| 2025-09-30 | -$1.18 10-Q · filed 2025-11-13 | -$1.45 10-Q · filed 2025-11-13 | ||||
| 2025-06-30 | -$0.09 10-Q · filed 2026-08-12 | -$0.19 10-Q · filed 2026-08-12 | ||||
| 2025-03-31 | -$0.11 10-Q · filed 2026-05-14 | |||||
| 2024-12-31 | -$0.14 derived: net income ÷ weighted average shares · filed 2026-03-31 | -$0.28 derived: net income ÷ weighted average shares · filed 2026-03-31 | -$0.51 10-K · filed 2026-03-31 | |||
| 2024-09-30 | -$0.14 10-Q · filed 2025-11-13 | -$0.36 10-Q · filed 2025-11-13 | ||||
| 2024-06-30 | -$0.11 10-Q · filed 2025-08-14 | -$0.23 10-Q · filed 2025-08-14 | ||||
| 2024-03-31 | -$0.15 10-Q · filed 2025-05-14 | -$0.12 10-Q · filed 2024-05-13 | ||||
| 2023-12-31 | -$0.85 10-K · filed 2025-03-28 | -$0.64 10-K · filed 2024-04-01 | ||||
| 2023-09-30 | -$0.26 10-Q · filed 2024-11-12 | -$0.45 10-Q · filed 2024-11-12 | ||||
| 2023-06-30 | -$0.10 10-Q/A · filed 2024-08-16 | -$0.20 10-Q/A · filed 2024-08-16 | ||||
| 2023-03-31 | -$0.10 10-Q · filed 2024-05-13 | |||||
| 2022-12-31 | -$0.40 10-K · filed 2024-04-01 | |||||
| 2022-09-30 | -$0.14 10-Q · filed 2023-11-13 | -$0.43 10-Q · filed 2023-11-13 | ||||
| 2022-06-30 | -$0.19 10-Q · filed 2023-09-15 | -$0.30 10-Q · filed 2023-09-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B |